- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
| Image | CAS No. | Purity | API Name | Last Drug Patent Expires | Details |
|---|---|---|---|---|---|
![Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/ljBpqKkrllSRpjomqionip/3680-60-60.gif) | 3680-69-1 | Ruxolitinib, Tofacitinib, Ritlecitinib, Baricitinib, Abrocitinib, Delgocitinib | 5/5/2041 (Ruxolitinib); 3/14/2034 (Tofacitinib); 12/3/2034 (Ritlecitinib); 11/30/2032 (Baricitinib); 2/19/2034 (Abrocitinib) | View detail » | |
 | 1207853-23-3 | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | 1227917-63-6 | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | 1207947-49-6 | Ritlecitinib | 12/3/2034 (Ritlecitinib) | View detail » | |
 | 151266-23-8 | 99% min (HPLC) | Futibatinib | 11/05/2039 (Futibatinib) | View detail » |
 | 871-70-5 | 98.0% min. by HPLC | Semaglutide | 2/17/2041 (Semaglutide) | View detail » |
 | 2061897-68-3 | Semaglutide | 2/17/2041 (Semaglutide) | View detail » | |
 | 1169630-40-3 | Semaglutide | 2/17/2041 (Semaglutide) | View detail » | |
 | 1414976-14-9 | 98.0% min (HPLC); 99.0% e.e (HPLC) | Zavegepant | 10/7/2031 (Zavegepant) | View detail » |
 | 35824-91-0 | 98% min (HPLC) | Daprodustat | 3/13/2038 (Daprodustat) | View detail » |
 | 855778-84-6 | 98% min (HPLC) | Zavegepant | 10/7/2031 (Zavegepant) | View detail » |
 | 349535-15-5 | 98% min (GC) | Zavegepant | 10/7/2031 (Zavegepant) | View detail » |
 | 23995-88-2 | 98% min (GC) | Zavegepant | 10/7/2031 (Zavegepant) | View detail » |
 | 1169630-82-3 | 98.0% min. by HPLC / GC | Semaglutide | 2/17/2041 (Semaglutide) | View detail » |
 | 139262-23-0 | 99% min (HPLC) | Semaglutide | 2/17/2041 (Semaglutide) | View detail » |
![Cas No. 2778223-52-0, Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis-](http://imrorwxhnlprli5q.ldycdn.com/cloud/jnBpqKkrllSRikiijlioin/2778223-60-60.gif) | 2778223-52-0 | 99.0% min (HPLC); 98.3% (Chiral Purity) | Pralsetinib | 4/3/2039 (Pralsetinib) | View detail » |
 | 1118767-16-0 | 98% min (HPLC) | Semaglutide | 2/17/2041 (Semaglutide) | View detail » |
 | 843666-40-0 | 98% min (HPLC) | Semaglutide | 2/17/2041 (Semaglutide) | View detail » |
 | 171290-52-1 | 97% min (HPLC) | Futibatinib | 11/05/2039 (Futibatinib) | View detail » |
 | 109431-87-0 | 98.0% min (HPLC); 99.0% min (Chiral) | Futibatinib | 11/05/2039 (Futibatinib) | View detail » |
